Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.66 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.66 |
| ▸ | TTR | P02766 | 1/20 | 0.66 |
| ▸ | PPOX | P50336 | 1/20 | 0.66 |
| ▸ | FFAR1 | O14842 | 5/20 | 0.48 |
| ▸ | LMNA | P02545 | 5/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.39 |
| ▸ | PTGDR2 | Q9Y5Y4 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | CCR6 | P51684 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | PYGL | P06737 | 1/20 | 0.37 |
| ▸ | IDO1 | P14902 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2809126 | 1.00 | MEN1 (0.66) | MEN1KMT2ATDP1TTRPPOX | |
| SCHEMBL203524 | 1.00 | MEN1 (0.66) | MEN1KMT2ATDP1TTRPPOX | |
| SCHEMBL29908511 | 0.92 | MEN1 (0.62) | MEN1KMT2ATDP1TTRPPOX | |
| SCHEMBL29414031 | 0.92 | MEN1 (0.62) | MEN1KMT2ATDP1TTRPPOX | |
| SCHEMBL29392315 | 0.92 | MEN1 (0.62) | MEN1KMT2ATDP1TTRPPOX | |
| SCHEMBL8187095 | 0.92 | MEN1 (0.62) | MEN1KMT2ATDP1TTRPPOX | |
| SCHEMBL8187092 | 0.92 | MEN1 (0.62) | MEN1KMT2ATDP1TTRPPOX | |
| SCHEMBL10379059 | 0.90 | MEN1 (0.59) | MEN1KMT2ATDP1TTRPPOX | |
| SCHEMBL4099716 | 0.89 | MEN1 (0.65) | MEN1KMT2ATDP1TTRPPOX | |
| SCHEMBL10698300 | 0.89 | TDP1 (0.67) | MEN1KMT2ATDP1TTRPPOX |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 327 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-63066156-A | — | — | None | — | — | JP | disclosed |
| US-20240188560-A1 | STABLE EMULSIONS | ADAMA AGAN LTD. (IL) | 2024-06-13 | — | — | US | disclosed |
| EP-3428148-B1 | ARYLOAZOL-2-YL CYANOETHYLAMINO COMPOUNDS, METHOD OF MAKING AND METHOD OF USING THEREOF | BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC (US) | 2020-07-08 | — | — | EP | disclosed |
| EP-3428148-A1 | ARYLOAZOL-2-YL CYANOETHYLAMINO COMPOUNDS, METHOD OF MAKING AND METHOD OF USING THEREOF | Merial, Inc. (US) | 2019-01-16 | — | — | EP | disclosed |
| EP-3088384-B1 | ARYLOAZOL-2-YL CYANOETHYLAMINO COMPOUNDS, METHOD OF MAKING AND METHOD OF USING THEREOF | MERIAL INC (US) | 2018-12-12 | — | — | EP | disclosed |
| US-9801374-B2 | Active compound combinations comprising carboxamide derivatives | BAYER CROPSCIENCE AG (DE) | 2017-10-31 | — | — | US | disclosed |
| EP-3088384-A1 | ARYLOAZOL-2-YL CYANOETHYLAMINO COMPOUNDS, METHOD OF MAKING AND METHOD OF USING THEREOF | Merial, Inc. (US) | 2016-11-02 | — | — | EP | disclosed |
| EP-2155699-B9 | ARYLOAZOL-2-YL CYANOETHYLAMINO COMPOUNDS, METHOD OF MAKING AND METHOD OF USING THEREOF | MERIAL INC (US) | 2016-09-14 | — | — | EP | disclosed |
| EP-2639228-B1 | Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof | MERIAL INC (US) | 2016-07-13 | — | — | EP | disclosed |
| US-9339033-B2 | 1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof | MERIAL, INC. (US) | 2016-05-17 | — | — | US | disclosed |
| US-5571772-A | Mixtures of triazine sulfonylurea herbicides and pyrazoline safeners | HOECHST SCHERING AGREVO GMBH (DE) | 1996-11-05 | — | — | US | disclosed |
| WO-1996031517-A1 | HERBICIDAL HETEROARYL-SUBSTITUTED ANILIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-10-10 | — | — | WO | disclosed |
| WO-1996013977-A2 | HERBICIDAL MIXTURES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-05-17 | — | — | WO | disclosed |
| WO-1995033746-A1 | CYCLIC SULFONAMIDE HERBICIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-12-14 | — | — | WO | disclosed |
| US-5463081-A | Chemical intermediates | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-10-31 | — | — | US | disclosed |
| US-5449812-A | Substituted benzenesulfonamide derivatives | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-09-12 | — | — | US | disclosed |
| US-5446013-A | 2-alkyl-or-aryl-substituted-2-(pyrimidinyl-or-traizinyl-oxy(or-thio))-acotic acid derivatives, process for preparation, and use as herbicides or plant-growth regulators | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-08-29 | — | — | US | disclosed |
| EP-0574418-A1 | ARYL SULPHONYL UREA COMPOUNDS, A METHOD OF PREPARING THEM, AND THEIR USE AS HERBICIDES AND GROWTH REGULATORS | Hoechst Schering AgrEvo GmbH (DE) | 1993-12-22 | — | — | EP | disclosed |
| WO-1992013845-A1 | ARYL SULPHONYL UREA COMPOUNDS, A METHOD OF PREPARING THEM, AND THEIR USE AS HERBICIDES AND GROWTH REGULATORS | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-08-20 | — | — | WO | disclosed |
| JP-S6366156-A | MOLECULAR COMPOUND AND PRODUCTION THEREOF | ASAHI CHEM IND CO LTD | 1988-03-24 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240188560-A1 | STABLE EMULSIONS | POLR2H, POLR2E, PHOSPHO1 | MEN1 4071/4885KMT2A 3666/4885TDP1 631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.